Molecular Discovery’s BioGPS enables binding site comparison using their GRID Molecular Interaction Fields and corresponding pharmacophoric fingerprints. A curated database can be searched using a template query cavity to identify sites (and any co-crystallised ligands) that are similar from the perspective of a ligand, making it an ideal structure-based approach to drug repurposing.